JP Morgan Private Wealth Advisors’s Catheter Precision VTAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2
Closed -$8K 2031
2022
Q1
$8K Buy
+2
New +$13.6K ﹤0.01% 1992

Other funds holding VTAK

JP Morgan Private Wealth Advisors's VTAK Position: Q2 2022 in Review

JP Morgan Private Wealth Advisors sold out of Catheter Precision (VTAK) in Q2 2022, closing a stake of 2 shares — an estimated $8K sold.

JP Morgan Private Wealth Advisors first reported a position in VTAK in Q1 2022 and held it in 1 quarter. The position peaked at $8K in Q1 2022. 16 funds tracked by Wall St. Rank hold VTAK as of Q2 2022.

  • JP Morgan Private Wealth Advisors reported no remaining Catheter Precision position as of Q2 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 2 Catheter Precision shares in Q2 2022, an estimated $8K.
  • JP Morgan Private Wealth Advisors first reported a position in Catheter Precision in Q1 2022 and held it in 1 quarter.
  • JP Morgan Private Wealth Advisors's Catheter Precision position peaked at $8K in Q1 2022.
  • 16 funds tracked by Wall St. Rank held Catheter Precision as of Q2 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q2 2022, filed 16 Aug 2022.